In a bid to capture new frontiers in intellectual property legal needs in the life sciences and biotech arenas, K&L Gates has added a team of IP professionals from a Boston boutique specializing in technologies that have yet to go to market.

Led by partners Hannah Koyfman and David Lu, the group brings multimillion-dollar books of business, consisting of clients developing cancer therapies, personalized medicine, CRISPR technologies and biologics. They come from Boston firm Lando & Anastasi.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]